OPTIMER PHARMACEUTICALS, INC. COM STK
OPTR
OPTR was delisted on the 23rd of October, 2013.
0 hedge funds and large institutions have $0 invested in OPTIMER PHARMACEUTICALS, INC. COM STK in 2013 Q4 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 103 closing their positions.
100% less funds holding
Funds holding: 104 → 0 (-104)
100% less capital invested
Capital invested by funds: $526M → $0 (-$526M)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 103
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
WIC
Water Island Capital
New York
|
-$37M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
-$34.3M |
| 3 |
Fidelity Investments
Boston,
Massachusetts
|
-$33.3M |
| 4 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$31.1M |
| 5 |
State Street
Boston,
Massachusetts
|
-$28.1M |
OPTR Hedge Fund Activity: Q4 2013 in Review
0 of the 3,447 institutional investors tracked by Wall St. Rank reported a position in OPTIMER PHARMACEUTICALS, INC. COM STK (OPTR) for Q4 2013, worth a combined $0 — down 100% from $526M a quarter earlier.
Sellers outnumbered buyers: 103 funds closed out of OPTR and 0 opened new positions — a net loss of 103 holders — while 0 trimmed existing stakes and 0 added.
The largest seller was Water Island Capital, exiting entirely with an estimated $37M sold.
- 0 institutional investors held OPTIMER PHARMACEUTICALS, INC. COM STK (OPTR) as of Q4 2013, down from 104 in Q3 2013.
- Funds reported $0 of OPTIMER PHARMACEUTICALS, INC. COM STK stock for Q4 2013, down 100% quarter-over-quarter.
- 0 funds opened new OPTIMER PHARMACEUTICALS, INC. COM STK positions in Q4 2013 and 103 closed out, a net change of -103 holders.
- The largest OPTIMER PHARMACEUTICALS, INC. COM STK seller in Q4 2013 was Water Island Capital, an estimated $37M sold.
Based on aggregated 13F filings for Q4 2013.